+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Fabry Disease Treatment Market Research Report by Treatment Type, Drugs, Route of Administration, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 252 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989675
UP TO OFF until Dec 31st 2022
The Global Fabry Disease Treatment Market size was estimated at USD 2,134.00 million in 2021, USD 2,308.83 million in 2022, and is projected to grow at a CAGR of 8.36% to reach USD 3,456.52 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Fabry Disease Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment Type, the market was studied across Chaperone Treatment, Enzyme Replacement Therapy, Organ-specific Treatment, and Substrate Reduction Therapy.
  • Based on Drugs, the market was studied across Agalsidase Beta, Migalastat, and Pipeline Drugs.
  • Based on Route of Administration, the market was studied across Intravenous and Oral.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Fabry Disease Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Fabry Disease Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Fabry Disease Treatment Market, including Amicus Therapeutics Inc., Avrobio Inc., Greenovation Biotech GmbH, Idorsia Pharmaceuticals Ltd., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Moderna Therapeutics Inc., Protalix Biotherapeutics Inc., Sanofi S.A., and Shire Plc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Fabry Disease Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Fabry Disease Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Fabry Disease Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Fabry Disease Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Fabry Disease Treatment Market?
6. What is the market share of the leading vendors in the Global Fabry Disease Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Fabry Disease Treatment Market?
Frequently Asked Questions about the Global Fabry Disease Treatment Market

What is the estimated value of the Global Fabry Disease Treatment Market?

The Global Fabry Disease Treatment Market was estimated to be valued at $2134 Million in 2021.

What is the growth rate of the Global Fabry Disease Treatment Market?

The growth rate of the Global Fabry Disease Treatment Market is 8.3%, with an estimated value of $3456.52 Million by 2027.

What is the forecasted size of the Global Fabry Disease Treatment Market?

The Global Fabry Disease Treatment Market is estimated to be worth $3456.52 Million by 2027.

Who are the key companies in the Global Fabry Disease Treatment Market?

Key companies in the Global Fabry Disease Treatment Market include Amicus Therapeutics Inc., Avrobio Inc., Greenovation Biotech GmbH, Idorsia Pharmaceuticals Ltd., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Moderna Therapeutics Inc., Protalix Biotherapeutics Inc. and Shire Plc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for messenger RNA as a treatment modality for Fabry disease
5.1.1.2. Adoption of novel therapies
5.1.1.3. Growing incidences of genetic disorders and increasing awareness
5.1.2. Restraints
5.1.2.1. Lack of awareness about advancements with respect to treatments for Fabry disease
5.1.2.2. High cost associated with the enzyme replacement therapy
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for the treatment of Fabry disease
5.1.3.2. Increasing healthcare expenditure and improving infrastructure in emerging economies
5.1.3.3. Increasing number of clinical trials
5.1.4. Challenges
5.1.4.1. Limitations in adopting new technologies in certain countries
5.2. Cumulative Impact of COVID-19
6. Fabry Disease Treatment Market, by Treatment Type
6.1. Introduction
6.2. Chaperone Treatment
6.3. Enzyme Replacement Therapy
6.4. Organ-specific Treatment
6.5. Substrate Reduction Therapy
7. Fabry Disease Treatment Market, by Drugs
7.1. Introduction
7.2. Agalsidase Beta
7.3. Migalastat
7.4. Pipeline Drugs
8. Fabry Disease Treatment Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
9. Americas Fabry Disease Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Fabry Disease Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Fabry Disease Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Amicus Therapeutics Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Avrobio Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Greenovation Biotech GmbH
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Idorsia Pharmaceuticals Ltd.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. ISU Abxis Co Ltd.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. JCR Pharmaceuticals Co Ltd.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Moderna Therapeutics Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Protalix Biotherapeutics Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Sanofi S.A.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Shire Plc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL FABRY DISEASE TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL FABRY DISEASE TREATMENT MARKET DYNAMICS
FIGURE 11. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT TYPE, 2027
FIGURE 14. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY CHAPERONE TREATMENT, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORGAN-SPECIFIC TREATMENT, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2021 VS 2027 (%)
FIGURE 19. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUGS, 2027
FIGURE 21. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY AGALSIDASE BETA, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY MIGALASTAT, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY PIPELINE DRUGS, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 25. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 27. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
FIGURE 29. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 31. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 32. AMERICAS FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 33. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. CANADA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 39. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 41. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 43. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 44. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 45. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. CHINA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. INDIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. TAIWAN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. VIETNAM FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 61. DENMARK FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. EGYPT FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. FINLAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. ISRAEL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. ITALY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. NIGERIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. NORWAY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. POLAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. QATAR FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. SWEDEN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. SWITZERLAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. TURKEY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. GLOBAL FABRY DISEASE TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 83. GLOBAL FABRY DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 84. GLOBAL FABRY DISEASE TREATMENT MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL FABRY DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY CHAPERONE TREATMENT, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY CHAPERONE TREATMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY CHAPERONE TREATMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORGAN-SPECIFIC TREATMENT, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORGAN-SPECIFIC TREATMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORGAN-SPECIFIC TREATMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY SUBSTRATE REDUCTION THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY AGALSIDASE BETA, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY AGALSIDASE BETA, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY AGALSIDASE BETA, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY MIGALASTAT, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY MIGALASTAT, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY MIGALASTAT, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY PIPELINE DRUGS, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY PIPELINE DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY PIPELINE DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL FABRY DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 38. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 39. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 40. AMERICAS FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 41. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 43. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 44. ARGENTINA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 45. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 47. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 48. BRAZIL FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 49. CANADA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. CANADA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 51. CANADA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 52. CANADA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 53. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 54. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 55. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 56. MEXICO FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 57. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 58. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 59. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 60. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 61. UNITED STATES FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 62. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 66. ASIA-PACIFIC FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 67. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 68. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 69. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 70. AUSTRALIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 71. CHINA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 72. CHINA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 73. CHINA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 74. CHINA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 75. INDIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 76. INDIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 77. INDIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 78. INDIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 79. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 80. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 81. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 82. INDONESIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 83. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 84. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 85. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 86. JAPAN FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 87. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 88. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 89. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 90. MALAYSIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 91. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 92. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 93. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 94. PHILIPPINES FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 95. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 96. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 97. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 98. SINGAPORE FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 99. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 100. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 101. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 102. SOUTH KOREA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 103. TAIWAN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 104. TAIWAN FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 105. TAIWAN FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 106. TAIWAN FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 107. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 109. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 110. THAILAND FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 111. VIETNAM FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. VIETNAM FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 113. VIETNAM FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 114. VIETNAM FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 120. DENMARK FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. DENMARK FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 122. DENMARK FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 123. DENMARK FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 124. EGYPT FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 125. EGYPT FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 126. EGYPT FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 127. EGYPT FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 128. FINLAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 129. FINLAND FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 130. FINLAND FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 131. FINLAND FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 132. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 134. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 135. FRANCE FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 136. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 137. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 138. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 139. GERMANY FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 140. ISRAEL FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 141. ISRAEL FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 142. ISRAEL FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 143. ISRAEL FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 144. ITALY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. ITALY FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 146. ITALY FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 147. ITALY FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 148. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 149. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 150. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 151. NETHERLANDS FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 152. NIGERIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 153. NIGERIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 154. NIGERIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 155. NIGERIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 156. NORWAY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 157. NORWAY FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 158. NORWAY FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 159. NORWAY FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 160. POLAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 161. POLAND FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 162. POLAND FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 163. POLAND FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 164. QATAR FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 165. QATAR FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 166. QATAR FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 167. QATAR FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 168. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 169. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 170. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 171. RUSSIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 172. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 173. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 174. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 175. SAUDI ARABIA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 176. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 177. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 178. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 179. SOUTH AFRICA FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 180. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 181. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 182. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 183. SPAIN FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 184. SWEDEN FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 185. SWEDEN FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 186. SWEDEN FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 187. SWEDEN FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 188. SWITZERLAND FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 189. SWITZERLAND FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 190. SWITZERLAND FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 191. SWITZERLAND FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 192. TURKEY FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 193. TURKEY FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 194. TURKEY FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 195. TURKEY FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 200. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 201. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 202. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 203. UNITED KINGDOM FABRY DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 204. GLOBAL FABRY DISEASE TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 205. GLOBAL FABRY DISEASE TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 206. GLOBAL FABRY DISEASE TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 207. GLOBAL FABRY DISEASE TREATMENT MARKET RANKING, BY KEY PLAYER, 2021
TABLE 208. GLOBAL FABRY DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 209. GLOBAL FABRY DISEASE TREATMENT MARKET MERGER & ACQUISITION
TABLE 210. GLOBAL FABRY DISEASE TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 211. GLOBAL FABRY DISEASE TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 212. GLOBAL FABRY DISEASE TREATMENT MARKET INVESTMENT & FUNDING
TABLE 213. GLOBAL FABRY DISEASE TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 214. GLOBAL FABRY DISEASE TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Amicus Therapeutics Inc.
  • Avrobio Inc.
  • Greenovation Biotech GmbH
  • Idorsia Pharmaceuticals Ltd.
  • ISU Abxis Co Ltd.
  • JCR Pharmaceuticals Co Ltd.
  • Moderna Therapeutics Inc.
  • Protalix Biotherapeutics Inc.
  • Sanofi S.A.
  • Shire Plc.

Methodology

Loading
LOADING...